The provided document contains information about a security vulnerability, **CVE-2022-47376**, affecting Alaris™ Infusion Central software versions 1.1 to 1.3.2.

**Root cause of vulnerability:**
The Alaris™ Infusion Central software may store a recoverable password after installation.

**Weaknesses/vulnerabilities present:**
- Recoverable password vulnerability.

**Impact of exploitation:**
- High impact to confidentiality and integrity of data due to potential disclosure and tampering of personal data.
- Partial impact to availability of data.
- No direct impact to patient safety as the software does not control the infusion pumps, but some installations may store personal data.

**Attack vectors:**
- Local access to the Alaris™ Infusion Central server is required.

**Required attacker capabilities/position:**
- The attacker needs to have local access to the Windows operating system on the Alaris™ Infusion Central server.
- They need to be able to recover the stored password.

The document also mentions that BD is reaching out to affected customers and has revised the installation procedure to prevent this vulnerability in future installations. It also provides mitigations such as periodic password changes and physical access controls.